Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Three Amigos Stock Thread -- Ignore unavailable to you. Want to Upgrade?

To: Ditchdigger who wrote (18035)	12/24/1999 11:11:00 AM
From: Sergio H	Respond to of 29382

DD, at the end of Nov. I put some of my retirement money in Fidelity's biotech. I passed over Janus' biotech because it was too loaded up in one stock....Amgen. You might as well buy Amgen <gggg>. Another mutual fund that I chose is FICDX - a play on Canada and natural resources....but back to biotechs, nice site and article: biospace.com <Triple Your Pleasure -- Folks At BioSpace.com Say That A Whole Crop Of Drugs Is Entering Later Stages Of Clinical Trials And Wall Street Is Taking Notice Folks at Biospace.com, a Web site that covers the biotech industry, say that a whole crop of drugs is entering later stages of clinical trials and Wall Street is taking notice. Add to that the recent leaps in genetic engineering and the fact that a lot of the loser companies that started out in the 90s are dead, and you've got a great crop of life-sciences companies to pick from. One company, for example, has figured out a way to put DNA segments on microchips. Another company, Incyte, recently announced it had found the gene involved in Type 2 diabetes. "In large part the boom comes back to the tremendous gains that have been made in genomics and bioinformatics," said Timothy Fredel, CEO of Biospace.com. "In the life-sciences industry you see value creation over a long period of time. People [are getting] concerned about Internet valuations. Investors look for other sectors where there's value." >